As of 2023, the Netherlands had the highest prevalence of cocaine use in Europe at three percent of the population having used in the previous year. This was followed by Spain and Ireland, with 2.4 percent and 2.3 percent of their respective populations using cocaine in this period. Breakdown of cocaine users in the Netherlands When broken down by age, the highest prevalence of cocaine users in the Netherlands is found in early adulthood. Almost seven percent of those aged 25 to 29 years used cocaine in 2021, and around 17 percent of this age group had tried it at least once in their life.Harms of cocaine useIn 2022, over 2.6 thousand people in the Netherlands entered drug treatment as a result of cocaine use. Furthermore, in the last 15 years, the annual number of deaths due to cocaine use in the country has been steadily increasing. A new-high was reached in 2021, with 72 cocaine deaths recorded in the Netherlands.

According to the latest estimates there were around 22 million cocaine users worldwide with the highest number found in the Americas. Cocaine is made from the leaves of the coca plant and is an addictive stimulant that is usually snorted as a powder. Although it is illegal in most countries it is still commonly used recreationally.

Cocaine worldwide

It is estimated that up to .5 percent of the global population has used cocaine in the past year. With so many users it is unsurprising that the illegal cocaine market is extremely lucrative. Worldwide illicit cultivation of cocaine covers some 234 thousand hectares, with most of the world’s cocaine produced in South America.

Cocaine in the United States

According to the most recent figures around 4.77 million people in the United States had used cocaine in the previous year. Moreover, around 40.9 million Americans have used cocaine at some point in their lifetime. In 2021, there were around 24,486 deaths involving cocaine in the United States, a significant rise from previous years. However, it is important to note that a large portion of deaths from cocaine involve the use of other drugs, specifically opioids.

In 2021/2022, the states with the highest share of people who had used cocaine in the past year were Colorado, Vermont, the District of Columbia, Rhode Island and Massachusetts. In Colorado, around 3.06 percent of the population were estimated to have used cocaine in the past year at that time, compared to the U.S. average of 1.95 percent. The states with the lowest past-year cocaine consumption rates were New Hampshire and Wyoming. Cocaine use in the United States As of 2022, cocaine was the second most used illicit drug in the United States, behind marijuana. At that time around 42.2 million people in the U.S. had used cocaine at least once in their lifetime. In comparison, around 29.5 million people reported using LSD in their lifetime and 22.1 million had used ecstasy. In 2022, almost 5.2 million people were estimated to have used cocaine in the past year. How many people in the U.S. die from cocaine every year? The number of drug poisoning deaths involving cocaine has increased significantly over the past couple decades. In 2021, there were around 24,486 overdose deaths involving cocaine, compared to just 3,800 in the year 1999. However, it is important to note that many overdose deaths involving cocaine also involve other drugs, namely opioids. The increase in overdose deaths involving cocaine is directly related to the ongoing opioid epidemic in the United States. Rates of overdose death involving cocaine are twice as high for men than women, but death rates for both men and women have increased in recent years.

The global Cocaine Intoxication Treatment Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Cocaine Intoxication Treatment registered a CAGR of 4% in the historical period 2018 to 2022.

Report Attribute	Details
Expected Market Value (2023)	US$10 Million
Anticipated Forecast Value (2033)	US$ 17.91 Million
Projected Growth Rate (2023 to 2033)	6% CAGR

Report Scope

Report Attribute	Details
Market Value in 2023	US$10 Million
Market Value in 2033	US$ 17.91 Million
Growth Rate	CAGR of 6% from 2023 to 2033
Base Year for Estimation	2022
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	Revenue in USD Million and CAGR from 2023 to 2033
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Drug class Route of Administration Distribution Channel Region
Regions Covered	North America Latin America Europe South Asia East Asia Oceania Middle East & Africa
Key Countries Profiled	USA Canada Brazil Mexico Rest of Latin America Germany United Kingdom France Spain Italy Rest of Europe Malaysia Singapore China India Thailand Rest of South Asia Gulf Cooperation Council Japan South Korea Australia New Zealand GCC countries South Africa Israel Rest of MEA
Key Companies Profiled	Tonix Pharmaceutical, GlaxoSmithKline Plc., Bristol Myers Squibb Company, Pfizer Inc., Novartis AG, Teva Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Sun Pharmaceuticals Industries Ltd., and Advanz Pharmaceuticals
Customization	Available Upon Request

In 2023, it was estimated that over 42 million people in the United States had used cocaine at some point in their life. The number of people in the United States who stated they had used cocaine in the past month has fluctuated over the past decade, but over two million people reported they had used cocaine in the past month as of 2023. Cocaine use among teens The percentage of U.S. students in grades 8, 10, and 12 that had used cocaine in their lifetime has gradually decreased since 1999. At that time, around 7.2 percent of students stated they had used cocaine in their lifetime, while in 2021 just 1.4 percent of students said so. Perhaps unsurprisingly, perceived availability of cocaine among 12th graders has also decreased over the past couple decades, with about 17 percent of 12th graders stating cocaine was “fairly easy” or “very easy” to get in 2021, compared to almost 55 percent who reported it was easy to get in 1990. The most common illicit drugs U.S. students in grades 8, 10, and 12 reported having used in their lifetime were marijuana, inhalants, and hallucinogens such as LSD and mushrooms. Deaths from cocaine In 2020, there were 19,447 drug poisoning deaths involving cocaine in the United States. The number of overdose deaths involving cocaine has increased significantly over the past few years as part of the ongoing opioid epidemic. Although, it is possible to die of an overdose just from using cocaine, many overdose deaths in the U.S. that involved cocaine also involved the use of opioids. The rate of overdose deaths involving cocaine is almost three times higher among men than women, but both have seen increases in the rate of overdose death in recent years. Considering race and ethnicity, the rate of overdose deaths involving cocaine is by far highest among black, non-Hispanics and lowest among Asian/Pacific Islander, non-Hispanics.

According to Cognitive Market Research, The Drug Abuse Testing Market will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031. North America held the major market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX % from 2024 to 2031. The Europe region is the fastest growing market with a CAGR of XX% from 2024 to 2031 and it is projected that it will grow at a CAGR of XX% in the future. Asia Pacific accounted for a market share of over XX% of the global revenue with a market size of USD XX million. Latin America had a market share for more than XX% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031. Middle East and Africa had a market share of around XX% of the global revenue and was estimated at a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031. The Drug Abuse Testing Market held the highest market revenue share in 2024.

Market Dynamics of The Drug Abuse Testing Market

Key Drivers for The Drug Abuse Testing Market

Increase in road accidents due to alcohol consumption growing the market for drug abuse testing.

The number of people killed and injured in traffic accidents, whether they occur right away or 30 days later, are the metrics used to assess these incidents. Alcohol and other substances impair reflexes, judgment, decision-making, impulse control, and motor function, which increases the risk of traffic accidents and frequently results in fatalities. The World Health Organization (WHO) estimates that between 20 and 50 million people get non-fatal injuries and 1.3 million people die in traffic accidents each year. Rising road accidents through alcohol consumption have increased drug abuse testing due to this the market is growing. For instance, according to the 2021 National Survey on Drug Use and Health (NSDUH), in 2021, around 57.8% of people aged 12 years and more used tobacco, alcohol, and illicit drugs. Further, 47.5% of them were alcohol consumers, 19.5% took tobacco, and 14.3% used illicit drugs. Additionally, it is well-known that men are more likely to consume drugs and alcohol than women. Source:(https://www.samhsa.gov/data/sites/default/files/2022-12/2021NSDUHFFRHighlights092722.pdf) For instance, in October 2023, In India, Kerala police launched a rapid drug screening system that uses saliva samples and gives results in five minutes. The hand-held device, the SoToxa Mobile Test System, has been deployed on a trial basis in Thiruvananthapuram city, and depending on its reliability and accuracy, the system will be expanded to other parts of the state as well. Over the past two days, the police have booked 11 people for narcotic abuse through a roadside drive using this device that helps in identifying those who took drugs even two days before Source:(https://www.onmanorama.com/news/kerala/2023/10/08/police-launch-new-device-detect-drug-use-in-5-minutes.html) After alcohol, marijuana is most frequently detected in the blood of drivers who have been in accidents. The mind-altering component of marijuana, delta-9-tetrahydrocannabinol (THC), which is found in blood, sometimes takes center stage during an inquiry. Furthermore, compared to when the substances are taken separately, marijuana may increase the risk of car accidents when combined with cocaine, alcohol, or benzodiazepines. Therefore, in the future, the frequency of drug misuse testing will be determined by the rising incidence of such adverse occurrences.

The increasing prevalence of drug abuse treatment drives growth in the drug abuse testing market. 

The increasing prevalence of drug abuse has led to a rising demand for drug abuse treatment, consequently driving growth in the drug abuse testing market. With a greater focus on identifying and addressing substance abuse issues, there's a corresponding need for accurate and efficient testing methods to monitor and manage treatment progress effectively. The growing consumption of illicit drugs by individuals needs to have drug abuse treatment which in turn increases the prevalence of drug abuse treatment hence it has led to drive the market growth of drug abuse testing. For instance,...

Snapshot img

Drugs Of Abuse Testing Market Size 2024-2028

The drugs of abuse testing market size is forecast to increase by USD 1.04 billion at a CAGR of 4.5% between 2023 and 2028. The market is experiencing significant growth, driven by increased strategic developments and the growing adoption of advanced information technology and information management solutions. These advancements in instruments enable efficient and accurate testing, reducing turnaround time and enhancing overall productivity. For instance, mass spectrometer and chromatography systems are extensively employed for the qualitative and quantitative analysis of cannabinoids in cannabis strains. However, high costs associated with the implementation and maintenance of these technologies remain a challenge for market expansion. Additionally, stringent regulations and the need for continuous innovation to keep up with emerging drugs of abuse are other key factors shaping the market landscape. Overall, the DoA testing market is expected to continue its growth trajectory, fueled by the need for workplace safety and substance abuse prevention.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market is driven by the increasing prevalence of prescription drug abuse, psychostimulants, fentanyl, vaping, and illicit drugs, as well as alcohol. Substance use disorders continue to be a significant public health concern in the US. Forensic laboratories and hospitals are major end-users, diagnostics with epidemiologic investigations and addiction treatment centers also contribute. Vulnerable populations such as the elderly, those with chronic pain, LIMS software, and individuals with opioid medications are key focus areas. Drugs like Fentanyl, psychostimulants, and cannabis/marijuana are common targets for testing.

Moreover, fentanyl, a powerful opioid, has emerged as a significant threat in the market. Its illegally manufactured forms are often mixed with other substances, making it difficult to detect and leading to a high number of overdose deaths. The elderly population is another vulnerable group in the market. They are at a higher risk of substance use disorders due to chronic pain and the misuse of prescription medications. Drug use statistics indicate that psychostimulants, such as cocaine and amphetamines, continue to be popular among certain demographics. Vaping, a newer form of drug delivery, has also gained popularity, particularly among the younger population.

Furthermore, real-time surveillance and epidemiologic investigations play a crucial role in identifying drug-related activity and addressing vulnerabilities in the market. Public awareness campaigns and drug testing mandates are essential tools in preventing substance use disorders and promoting addiction treatment. Cannabis, or marijuana, is another substance of interest in the market. While it is legal for medicinal and recreational use in some states, it is still illegal in others, making testing a necessity for employers and law enforcement agencies. The market is expected to grow due to the increasing need for accurate and reliable testing services. This growth is driven by the rising number of overdose deaths, addiction treatment initiatives, and public awareness campaigns.

In conclusion, the market is a critical component in addressing substance use disorders and promoting public health. It encompasses various sectors, including forensic laboratories and hospitals, and offers testing services for a range of substances, including prescription drugs, illicit drugs, and alcohol. The market is driven by various factors, including the increasing prevalence of substance use disorders, the emergence of new drugs and drug delivery methods, and the need for accurate and reliable testing services.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Instruments
  Consumables


Geography

  North America

    Canada
    US


  Europe

    Denmark


  Asia

    China
    India


  Rest of World (ROW)

By Product Insights

The instruments segment is estimated to witness significant growth during the forecast period. The market encompasses various systems, analyzers, and devices for detecting and quantifying different drug substances. These tools include breath analyzers, chromatography analyzers, immunoassay analyzers, urine testing devices, and oral fluid testing devices. For example, cannabis testing relies on mass spectrometers and chromatography systems to identify and measure the presence and quantity of cannabinoid compounds. Biotechnology plays a significant role in the market, as the principles of detection and quantification are similar to those used in foo

This statistic shows the worldwide production quantity of cocaine from 1994 to 2021. In 2021, the total production of cocaine worldwide was around 2,304 metric tons.

Snapshot img

Drug Screening Market Size 2024-2028

The drug screening market size is forecast to increase by USD 10.66 billion at a CAGR of 21.49% between 2023 and 2028. The market is experiencing robust growth due to several key factors. Advancements in drug screening technologies are driving innovation and improving accuracy and efficiency. These advancements include the use of biomarkers, molecular diagnostics, and point-of-care testing. Additionally, increased strategic developments by market players are expanding the market's scope and enhancing its competitiveness. Stringent workplace safety regulations also contribute to the market's growth, as employers seek to ensure a drug-free work environment. Moreover, consumer preferences are shifting towards more efficient and convenient drug screening solutions. This trend is driving the transition towards more automated and digital systems. Better accessibility to drug screening services is also a significant factor, as more employers and individuals seek to address substance abuse issues. Industry standards are continually evolving, and companies in this market are adjusting their strategies to meet these shifts.

What will be the size of the market during the forecast period?

Request Free Sample

Drug Screening Market Segmentation

The drug screening market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

Type

  Drug screening products
  Drug screening services


Application

  Urine samples
  Breath samples
  Hair and blood samples
  Oral fluid samples


Geography

  North America

    Canada
    US


  Europe

    Germany


  Asia

    China
    Japan


  Rest of World (ROW)

Which is the largest segment driving market growth?

The drug screening products segment is estimated to witness significant growth during the forecast period.

The market encompasses test kits, analyzers, and consumables, which are increasingly utilized for detecting illicit substances in various sectors. The market's growth is driven by escalating drug abuse, stringent regulatory requirements, and safety concerns in workplaces. Drug screening is essential in industries like transportation, healthcare, and construction to ensure regulatory compliance and workplace security. Technological advancements have led to the emergence of innovative and reliable drug screening solutions, further increasing market demand. Key players in this market include Abbott and Thermo Fisher, offering diverse product portfolios. Drug screening is crucial for identifying drug use in schools, hospitals, pain management facilities, drug treatment centers, and among individual users.

It addresses issues related to performance-enhancing drugs, banned substances, alcohol consumption, cannabis, opioids, and prescription medication abuse. The market caters to both personal and workplace needs, providing non-invasive, portable, time-saving, sanitary, and user-friendly solutions. Government policies, pharmaceutical development, and high-throughput screening technologies are shaping the drug screening industry's future.

Get a glance at the market share of various regions. Download the PDF Sample

The Drug screening products segment was valued at USD 2.35 billion in 2018 and showed a gradual increase during the forecast period.

Which region is leading the market?

North America is estimated to contribute 46% to the growth of the global market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.The Drug Screening industry in North America is experiencing significant growth due to stringent regulations and extensive drug testing programs in healthcare, transportation, and sporting sectors. Key drivers include the increasing incidence of drug abuse and the demand for workplace safety. In response to the opioid crisis, Quest Diagnostics introduced a new drug testing panel to detect fentanyl analogs. Technological advancements, such as point-of-care testing tools and laboratory information management systems (LIMS), are also contributing to market expansion. The regional market is expected to continue growing, with a focus on improving screening technology, reducing false positives and negatives, and addressing the use of performance enhancing drugs and banned substances.

The industry caters to various sectors, including pain management facilities, drug treatment centers, schools and colleges, hospitals, individual users, and law enforcement agencies. Drug screening services utilize various samples, such as urine, oral fluid, and hair, and employ analytical instruments, rapid test

The global Connected Drug Delivery Devices Market size was estimated at US$ 330 Million in 2021, and is expected to reach US$ 1.6 Billion by 2028, expanding at a stellar CAGR of 23.6%.

Attribute	Details
Connected Drug Delivery Devices Market Size (2022)	US$ 448 Million
Sales Forecast (2028)	US$ 1.6 Billion
Projected Market Growth Forecast (2022 to 2028)	23.6% CAGR
Regional Market With Highest Share	North America - 51.5%

How The Market Progressed Till June 2022?

Particulars	Details
H1, 2021	25.73%
H1, 2022 Projected	23.59%
H1, 2022 Outlook	22.79%
BPS Change - H1, 2022 (O) - H1, 2022 (P)	(-) 80 ↓
BPS Change - H1, 2022 (O) - H1, 2021	(-) 294 ↓

Connected Drug Delivery Devices Industry Report Scope

Attribute	Details
Forecast Period	2022 to 2028
Historical Data Available for	2015 to 2021
Market Analysis	US$ Million for Value, Units for Volume
Key Regions Covered	North America Latin America Europe East Asia South Asia & Pacific Middle East & Africa (MEA)
Key Countries Covered	United States Canada Brazil Mexico Germany UK France Spain Italy China Japan South Korea India Indonesia Malaysia Singapore Australia New Zealand Turkey South Africa and GCC Countries
Key Market Segments Covered	Product Type End User Application Technology Region
Key Companies Profiled	Bayer AG. Propeller Health West Pharmaceutical Services Inc. 3M Company OPKO Health Sagentia (Science Group) Care TRx CeQur SA Biocorp Production SA
Pricing	Available upon Request

The global drug eruptions treatment market is expected to be worth US$ 3.89 Billion in the fiscal year 2023, which rose up from US$ 3.66 Billion in the fiscal year 2022. From 2023 to 2033, the global market is expected to grow at a steady 6.2% CAGR, reaching a value of US$ 7.1 Billion by the end of 2033.

Attributes	Details
Expected Market Value (2023)	US$ 3.89 Billion
Projected Forecast Value (2033)	US$ 7.1 Billion
Global Growth Rate (2023 to 2033)	6.2%

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 6.2% from 2023 to 2033
Market value in 2023	US$ 3.89 Billion
Market value in 2033	US$ 7.1 Billion
Base Year for Estimation	2022
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	USD Billion for Value
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered	Drug class Route of Administration Distribution Channel Region
Regions Covered	North America Latin America Europe Asia Pacific Middle East & Africa (MEA)
Key Countries Profiled	United States of America Canada Mexico Brazil Rest of Latin America Germany Italy France United Kingdom Spain Rest of Europe Japan Singapore South Korea Thailand Indonesia China Australia New Zealand Japan GCC Countries South Africa Israel Middle East and Africa
Key Companies Profiled	Anuh Pharma Ltd. Avik Pharma Pfizer CentreOne Hovione Bausch Health Companies Inc. APOTEX Astellas Pharma, Inc. Sanofi Novartis AG SBH Sciences
Customisation Scope	Available on Request

The global Peptide Drug Conjugates market is anticipated to hold a market value of US$ 861.12 Million in 2023 and US$ 5,331.83 Million by 2033. The projected growth rate is nearly 20% during the forecast period from 2023 to 2033.

Report Attributes	Details
Estimated Market Value in 2023	US$ 861.12 Million
Estimated Market Value in 2033	US$ 5,331.83 Million
Projected CAGR from 2023 to 2033	20%

Peptide Drug Conjugates Market- Report Scope

Report Attributes	Details
Market Value in 2023	US$ 861.12 Million
Market Value in 2033	US$ 5,331.83 Million
Forecast Period	2023 to 2033
Historical Data	2018 to 2022
Quantitative Units	US$ Million for Value and CAGR from 2023 to 2033
Key Regions Covered	North America Latin America Europe Asia Pacific Middle East & Africa
Key Countries Covered	USA Canada Brazil Mexico Germany United Kingdom France Spain Italy Singapore Thailand China Japan South Korea Australia New Zealand GCC Countries South Africa Israel
Key Segments Covered	Type Product Region
Key Companies Profiled	Novartis AG Oncopeptides AB Bicycle Therapeutics AstraZeneca Cybrexa Therapeutics Angiochem Inc. Innovasium Soricimed Biopharma Theratechnologies Coherent Biopharma WuXI STA
Pricing	Available upon Request

Snapshot img

Drug Discovery Technology Market Size 2024-2028

The drug discovery technology market size is forecast to increase by USD 27.31 billion at a CAGR of 9.2% between 2023 and 2028.

The market experiences significant growth due to the increasing prevalence of chronic conditions such as cardiovascular diseases and diabetes. This market is driven by the introduction of innovative small molecule drug candidates and advanced technologies to expedite the drug discovery process. However, intellectual property (IP) issues arising from patent expiration pose a challenge in the development and commercialization of new therapies. As healthcare expenditure continues to rise, the demand for effective treatments and cures remains high, creating opportunities for market participants. This report provides a comprehensive analysis of the market trends, growth drivers, and challenges in the drug discovery sector.

What will the size of the market be during the forecast period?

Request Free Sample

The market encompasses the processes involved in identifying and developing new chemical compounds with therapeutic potential. This market plays a pivotal role in addressing the unmet medical needs of chronic diseases such as cardiovascular diseases, diabetes, cancer, respiratory diseases, neurological disorders, and others. The scientific research community continues to explore innovative treatments using various techniques, including the application of artificial intelligence (AI) and genomics in drug discovery. Small molecule drug discovery remains a significant focus, as these compounds offer potential solutions for various therapeutic areas. Furthermore, preclinical testing and clinical trials are crucial stages in the drug discovery process. These stages ensure the safety and efficacy of lead compounds before they can be approved for widespread use. Pharmaceutical companies invest substantial resources in these stages to bring new drugs to market. Healthcare expenditure and patent expiration are key drivers for the drug discovery technology market. As chronic diseases continue to rise, there is a growing demand for new treatments. Additionally, with the expiration of patents on many blockbuster drugs, pharmaceutical companies are under pressure to discover and develop new therapeutics.
Cardiovascular diseases, diabetes, and cancer are among the leading causes of death and disability worldwide. In addition, antiviral drugs have also gained significant attention due to the ongoing COVID-19 pandemic. The development of effective treatments for these conditions remains a priority for the drug discovery technology market. Biopharmaceuticals, which include proteins, peptides, and monoclonal antibodies, are also a significant focus in the drug discovery technology market. Lifestyle changes and environmental factors, such as pollution, can contribute to the development of various diseases. Therefore, continued research in drug discovery is essential to address these health concerns. Innovations in drug discovery technology, such as AI and genomics, offer promising opportunities for the market. These technologies can help accelerate the discovery process, reduce costs, and improve the success rate of bringing new drugs to market.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Genomics
  Proteomics
  Bioinformatics
  High-throughput screening (HTS)
  Others


End-user

  Pharmaceutical and biotechnology companies
  Academic and research institutes
  CROs


Geography

  North America

    US


  Europe

    Germany


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The genomics segment is estimated to witness significant growth during the forecast period.

The market is experiencing notable progress, with the genomics segment leading the way. This sector is marked by the adoption of advanced technologies that improve the accuracy and speed of genetic analysis, which is essential for creating novel therapeutic interventions. Genomics, which entails examining an organism's entire deoxyribonucleic acid (DNA), including all its genes, plays a pivotal role in drug discovery. The capacity to sequence and analyze genomes has revolutionized the identification of genetic markers linked to diseases, paving the way for personalized treatments.

Additionally, recent breakthroughs in genomics are propelling the market forward, as companies introduce sophisticated solutions aimed at revolutionizing cancer therapy and managing neurological disorders, such as Alzheimer's and Parkinson's diseases. These advancements are driven by the increasing prevalence of conditions

Global Drug Delivery Devices Market Size By Drug Delivery Route (Oral Drug Delivery And Injectable Drug Delivery), By End-User (Hospitals And Diagnostic Centers), By Application (Oncology And Infectious Diseases), By Geography Scope And Forecast

Snapshot img

Drug Delivery Devices Market Size 2024-2028

The drug delivery devices market size is forecast to increase by USD 85.1 billion at a CAGR of 6.2% between 2023 and 2028.

The market is experiencing significant growth due to the increasing prevalence of chronic conditions and the rising adoption of self-administering systems. Self-injectable devices, including auto-injectors and jet-injectors, are gaining popularity for their convenience and effectiveness in delivering drugs directly to the target site. However, bioavailability hurdles remain a challenge in oral delivery systems, leading to the increasing use of injectable routes. Pharmaceutical companies are investing heavily in research and development to address these challenges and create more efficient drug delivery systems.In healthcare, Retail pharmacies and hospital pharmacies are key distribution channels for these devices, ensuring easy access for patients. Stringent government regulations ensure the safety and efficacy of these devices, making them a reliable option for patients. The market is expected to continue growing as technology advances and new applications for drug delivery systems emerge.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

 The market represents a significant segment within the pharmaceutical industry, offering innovative solutions for the effective and efficient administration of active pharmaceutical ingredients (APIs) in various therapeutic areas. These devices cater to both chronic diseases and non-chronic diseases, and their usage extends to home-care environments, retail pharmacies, hospital pharmacies, and online pharmacies. Advanced technology plays a crucial role in the development of drug delivery devices. Next-generation technologies, such as self-administering systems, auto-injectors, pen injectors, jet-injectors, prefilled syringes, and smart sensors, have gained popularity due to their patient-friendly designs and improved accuracy. In the context of chronic diseases, drug delivery devices have proven to be essential for targeted medication delivery.
Biologics drugs, which often require specific delivery methods, have particularly benefited from these advancements. The pharmaceutical industry's focus on diagnosis and treatment has led to the integration of drug delivery devices in various vaccination drives and therapeutic areas. Oral drug delivery and injectable drug delivery systems have shown remarkable progress, offering enhanced patient compliance and convenience. Homecare solutions have emerged as a key area of growth within the market. These devices enable patients to administer medications in the comfort of their homes, reducing the need for frequent hospital visits and improving overall patient care.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Route Of Administration

  Oral
  Injectable
  Pulmonary
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia



  Rest of World (ROW)

By Route Of Administration Insights

The oral segment is estimated to witness significant growth during the forecast period.

The market for Drug Delivery Devices encompasses various types of devices used for administering drugs, including Injection Devices, Oral Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, and Nasal Drug Delivery. Among these, the segment for Oral Drug Delivery is significant due to its ease of use, non-invasive nature, and cost-effectiveness. This segment includes drugs in the form of capsules, tablets, syrups, solutions, and suspensions

Furthermore, orally administered drugs can be targeted to specific areas within the gastrointestinal tract to treat various conditions, including cancer, inflammation, infections, and bowel diseases. Advancements in pharmaceutical technologies and oral drug delivery systems, such as lipid-based carriers, nanocarriers, and micelles, are enhancing oral drug absorption, thereby improving therapeutic effectiveness. Hence, such factors are fuelling the growth of this segment during the forecast period.

Get a glance at the market report of share of various segments Request Free Sample

The oral segment was valued at USD 85.50 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 52% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sampl

7452 Global import shipment records of Drugs Drug with prices, volume & current Buyer's suppliers relationships based on actual Global export trade database.

Global Implantable Drug Eluting Devices Market is set to experience significant growth of 6.0% CAGR from 2022 to 2029, with an estimated market value of around US$ 12.8 Billion as of 2022. As per Future Market Insights projections, contraceptive drug eluting devices products hold a substantial share of over 39.8% in 2021 within the global market.

Data Points	Market Insights
Market Value 2021	US$ 12.1 Billion
Market Value 2022	US$ 12.8 Billion
Market Value 2029	US$ 19.3 Billion
CAGR 2022 to 2029	6.0%
Market Share of Top 5 Countries	76.5%

How The Market Progressed Till June 2022?

Particulars	Details
H1, 2021	6.03%
H1, 2022 Projected	6.00%
H1, 2022 Outlook	5.90%
BPS Change - H1, 2022 (O) – H1, 2022 (P)	(-) 10 ↓
BPS Change – H1, 2022 (O) – H1, 2021	(-) 13 ↓

Report Scope as per Implantable Drug Eluting Devices Market Analysis

Attribute	Details
Forecast Period	2022 to 2029
Historical Data Available for	2014 to 2021
Market Analysis	US$ Million for Value
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Northern Africa, South Africa, Turkey
Key Market Segments Covered	Product, Technology, Application, Implantation Type, End User, and Region
Key Companies Profiled	Pfizer Inc. Medtronic Inc. Merck & Co., In Bayer AG JOHNSON & JOHNSON SurModics Inc. AstraZeneca Plc. Boston Scientific Corporation Titan Pharmaceuticals, Inc. BIOTRONIK, INC. Abbott Laboratories Allergan, Inc. Bausch and Lomb, Inc. Alimera Sciences REVA Medical, Inc.
Pricing	Available upon Request

Pitch Coke Market size was valued at USD 1.9 Million in 2023 and is projected to reach USD 3.05 Million by 2030, growing at a CAGR of 7.2 % during the forecast period 2024-2030.

Global Pitch Coke Market Drivers

The market drivers for the Pitch Coke Market can be influenced by various factors. These may include:

Steel Industry Demand: The main application for pitch coke is as a raw material for the manufacture of graphite electrodes, which are essential parts of electric arc furnaces used to produce steel. Thus, the pitch coke market is directly impacted by the global demand for steel.

Growth of the Electric Vehicle (EV) Industry: As the demand for electric vehicles rises, so does the need for graphite electrodes, which are utilised in the manufacturing of lithium-ion batteries. Pitch coke’s market is sensitive to the expansion of the electric vehicle (EV) industry since it is a necessary raw material in the production of premium graphite electrodes.

Demand from the Aluminium Industry: Pitch coke is also used to make anodes for the smelting of aluminium. Pitch coke prices can be impacted by changes in the aluminium industry caused by things like building activity, auto production, or demand from the aerospace industry.

Environmental policies and government restrictions: Pitch coke production and consumption may be impacted by environmental regulations. Policies pertaining to emissions, waste management, and carbon footprint could have an impact on the processes utilised in the manufacturing of pitch coke and the sectors that consume it.

Technological developments: New methods for producing pitch coke or substitute materials for graphite electrodes can have an impact on the dynamics of the market. The market for pitch coke may shift in response to better manufacturing techniques or the identification of more effective alternatives.

Global Economic Conditions: The demand for pitch coke is influenced by industrial activity, which is influenced by economic factors including GDP growth, inflation rates, and currency fluctuations. A decline in demand from sectors such as the manufacturing of steel and aluminium can result from economic downturns.

Disruptions to the Global Supply Chain: The availability and cost of pitch coke can be impacted by a variety of factors, including labour strikes, natural disasters, and geopolitical unrest. Pitch coke is frequently produced from certain areas and needs particular refining procedures, therefore supply chain interruptions can have a big effect on the market.

The North America Animal Drug Compounding report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into capital flows and market shifts, guiding investors toward growth opportunities in key industry segments and regions.

Global Share of Scientific Publications Involving International Collaboration in Drug Discovery by Country, 2023 Discover more data with ReportLinker!